akhatri

As part of our Funding & Reimbursement Shorts series, Community Pharmacy England’s in-house Drug Tariff experts have created a new video to explain the dispensing and endorsing requirements for Controlled Drugs (CDs) prescribed on blue paper FP10MDA instalment prescription forms. In this video, Sarah Welbourne (Dispensing and Supply Officer) and Alisha Khatri (Dispensing and Supply Pharmacist) [...]

The post Funding & Reimbursement Shorts: Dispensing FP10MDA forms appeared first on Community Pharmacy England.

The NHS Business Services Authority (NHSBSA) produces a quarterly newsletter called “Hints & Tips”. The latest edition (Issue 63) contains some useful information and advice on: New Drug Tariff Category H products April 2026 Drug Tariff changes Reimbursement price changes: January, February and March 2026 Prescription endorsing: invoice prices Sorting your end of month batch [...]

The post NHSBSA ‘Hints & Tips’ – Issue 63 appeared first on Community Pharmacy England.

Following representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has re-determined that the following products will be granted special container status from 1 May 2026. Generic drug name (dm+d descriptor) Brand and/or manufacturer Pack Size Special container Budesonide 3mg gastro-resistant modified-release capsules Tillotts Pharma UK Ltd 100 capsules Complete pack Deferiprone [...]

The post 6 products re-classified as special containers from May 2026 appeared first on Community Pharmacy England.

MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) Drug Alert Number: EL(25)A/21 Date issued: 23 April 2026 Omega Pharma Ltd is recalling specific batches of Napralief 250mg Gastro-Resistant Tablets due to missing text in Section 2 and Section 3 of the Patient Information Leaflet (PIL) and on the Carton in packs of [...]

The post MHRA Class 3 Medicines Recall: Napralief 250mg Gastro-Resistant Tablets (Omega Pharma Ltd) appeared first on Community Pharmacy England.

MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) Drug alert number: EL(26)A/19 Date issued: 20 April 2026 Crescent Pharma Limited is recalling one batch of Ramipril 10mg Capsules as a precautionary measure due to a potential error at the manufacturing site. DMRC reference number: DMRC-39191133 Company name: Crescent Pharma Limited Medicine Details Ramipril [...]

The post MHRA Class 2 Medicines Recall: Ramipril 10mg capsules (Crescent Pharma Limited) appeared first on Community Pharmacy England.